Diagnostic Access to Self-Care and Health Services in Low and Middle Income Countries (DASH) - Phase II

NANot yet recruitingINTERVENTIONAL
Enrollment

2,250

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Malaria InfectionPregnancyHIVDiabetesHypertension
Interventions
OTHER

Home-based rapid testing

Participants will be provided with rapid diagnostic tests for HIV, pregnancy and malaria (in Kenya and Zambia only) for on-demand, at-home self testing if/when indicated.

OTHER

Community health worker rapid testing

Participants will have access to rapid testing through a community health worker who will conduct rapid testing in the home or at a community-based location when indicated.

Trial Locations (3)

Unknown

Kenya Medical Research Institute, Kisumu

Human Sciences Research Council, Durban

Center for Infectious Disease Research in Zambia, Lusaka

Sponsors
All Listed Sponsors
collaborator

Kenya Medical Research Institute

OTHER

collaborator

Centre for Infectious Disease Research in Zambia

OTHER

collaborator

Human Sciences Research Council

OTHER_GOV

collaborator

Bill and Melinda Gates Foundation

OTHER

lead

University of Washington

OTHER